Political Quotes

“Mr. Chairman, this is a bipartisan amendment that incorporates an interagency agreement transmitted to Congress by the Office of National Drug Control Policy, the United States Department of Health and Human Services, and the United States Department of Justice. It clarifies several issues: when the Attorney General can temporarily and permanently schedule a drug or substance to the newly created schedule A, and it prevents the Attorney General from permanently scheduling a drug or substance if the Secretary of HHS determines that there is not sufficient potential for abuse. It also clarifies when research can be conducted with a schedule A substance while a registration application is pending. If an applicant is registered to conduct research with a schedule I or II substance, they can continue to do research they may be pursuing with a schedule A substance while their application is being processed. Likewise, if an applicant is registered to conduct research with a schedule III, IV, or V substance, they can continue to conduct research with a schedule A substance while their application is pending, so long as the component that gave rise to the schedule A determination is in the same or a less restricted schedule. This amendment is important to research. This amendment will help ensure that research is not impeded or stunted because of a change in the schedule of a substance.…”